Viewing Study NCT04991051


Ignite Creation Date: 2025-12-24 @ 11:55 PM
Ignite Modification Date: 2026-06-21 @ 12:50 AM
Study NCT ID: NCT04991051
Status: COMPLETED
Last Update Posted: 2024-02-06
First Post: 2021-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Determine the Prevalence of Homologous Recombination Deficiency Among Women With Newly Diagnosed, High-grade, Serous or Endometrioid Ovarian, Primary Peritoneal, and/or Fallopian Tube Cancer
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fallopian Tube Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer, HRD-testing, ovarian View